Published in Proc Natl Acad Sci U S A on October 01, 1965
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
The specificity of interferon induction in chick embryo cells by helical RNA. Proc Natl Acad Sci U S A (1969) 2.12
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
Effect of acetoxycycloheximide and of an acetoxycycloheximide-puromycin mixture on cerebral protein synthesis and memory in mice. Proc Natl Acad Sci U S A (1966) 1.43
Interferon messenger RNA: translation in heterologous cells. Proc Natl Acad Sci U S A (1972) 1.32
Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A (1975) 1.27
The role of individual spleen cells in the interferon response of the intact mouse. Proc Natl Acad Sci U S A (1969) 1.05
Retinoic acid (vitamin A acid) induced transcriptional control of interferon production. Proc Natl Acad Sci U S A (1977) 0.91
Purified rabbit interferon: attempts to demonstrate interferon-specific 3H-protein. J Virol (1970) 0.89
Sedimentation characteristics of rapidly labelled RNA from HeLa cells. Biochem Biophys Res Commun (1962) 13.89
INHIBITION OF PROTEIN SYNTHESIS BY PUROMYCIN. Fed Proc (1965) 3.86
A dissociative effect of puromycin on the pathway of protein synthesis by Ehrlich ascites tumor cells. J Biol Chem (1962) 2.23
EFFECTS OF PUROMYCIN ON RNA SYNTHESIS IN MAMMALIAN CELLS. Proc Natl Acad Sci U S A (1963) 1.74
INHIBITION OF INTERFERON BIOSYNTHESIS BY ACTINOMYCIN D. Nature (1964) 1.73
INTERFERON. A REVIEW AND ANALYSIS OF RECENT OBSERVATIONS. Am J Med (1965) 1.54
METABOLIC DETERMINANTS OF INTERFERON FORMATION. Virology (1965) 1.52
EFFECTS OF PUROMYCIN AND P-FLUOROPHENYLALANINE ON MENGOVIRUS RIBONUCLEIC ACID AND PROTEIN SYNTHESIS. Biochim Biophys Acta (1963) 1.15
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Defective viral particles and viral disease processes. Nature (1970) 7.24
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. Virology (1970) 5.99
Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol (1972) 5.93
Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles. J Virol (1969) 5.73
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol (1970) 4.54
Protein composition of the structural components of vesicular stomatitis virus. J Virol (1969) 4.54
Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles. J Virol (1972) 4.48
Defective interfering viruses. Annu Rev Microbiol (1973) 4.21
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase. J Virol (1971) 3.34
L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol (1973) 3.26
Lipid composition of purified vesicular stomatitis viruses. J Virol (1971) 3.25
Initiation of polyribosome formation in poliovirus-infected HeLa cells. J Mol Biol (1970) 2.91
Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell (1985) 2.82
The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell (1978) 2.81
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75
Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus. J Virol (1971) 2.48
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
RNA synthesis of vesicular stomatitis virus. V. Interactions between transcription and replication. J Virol (1973) 2.44
Viral pathogenesis and molecular biology. Bacteriol Rev (1977) 2.41
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids. Virology (1974) 2.30
Isopycnic separation of subcellular components from poliovirus-infected and normal HeLa cells. Science (1968) 2.25
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1995) 2.23
Protein kinase and phosphoproteins of vesicular stomatitis virus. J Virol (1974) 2.11
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Effects of phosphorylation and pH on the association of NS protein with vesicular stomatitis virus cores. J Virol (1978) 2.08
Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins. J Virol (1971) 2.05
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Interaction of HeLa cell proteins with RNA. J Mol Biol (1970) 1.90
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies. J Virol (1986) 1.78
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol (1989) 1.73
Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles. Biochemistry (1981) 1.71
Association of polyadenylic acid with messenger RNA of vesicular stomatitis virus. J Mol Biol (1973) 1.68
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J Virol (1974) 1.63
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell (1982) 1.61
Glycoprotein biosynthesis. Incorporation of glycosyl groups into endogenous acceptors in a Golgi apparatus-rich fraction of liver. J Biol Chem (1971) 1.60
Shedding of the glycoprotein from vesicular stomatitis virus-infected cells. J Virol (1978) 1.59
Location of the transcription defect in group I temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1974) 1.58
Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity. J Virol (1975) 1.57
Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1976) 1.55
Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes. Biochemistry (1976) 1.54
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
The formation of poliovirus proteins. Cold Spring Harb Symp Quant Biol (1969) 1.52
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis. J Biol Chem (1979) 1.48
Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J Virol (1995) 1.46
Phosphoproteins of vesicular stomatitis virus: identity and interconversion of phosphorylated forms. Virology (1979) 1.46
Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun (1984) 1.45
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr (1990) 1.42
Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J Virol (1994) 1.39
Structural proteins of two salmonid rhabdoviruses. J Virol (1975) 1.36
Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus. Virology (1981) 1.34
Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. J Virol (1988) 1.33
Classification of the New Jersey serotype of vesicular stomatitis virus into two subtypes. J Virol (1978) 1.32
Enzymatic transfer of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine to endogenous acceptors in a Golgi apparatus-rich fraction from liver. Biochem Biophys Res Commun (1969) 1.32
Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production. Virology (1977) 1.31
Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system. J Virol (1991) 1.30
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus. J Virol (1975) 1.27
Influence of the peripheral matrix protein of vesicular stomatitis virus on the membrane dynamics of mixed phospholipid vesicles: fluorescence studies. Biochemistry (1983) 1.23
Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses. J Virol (1978) 1.22
Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell. J Virol (1976) 1.21
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature (1986) 1.21
RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNA's of vesicular stomatitis virus by duplex formation. J Virol (1977) 1.20
Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J Virol (1979) 1.20
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights. J Exp Med (1967) 1.16
RNA synthesis of vesicular stomatitis virus. VIII. Oligonucleotides of the structural genes and mRNA. Gene (1979) 1.16
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Interferon-mediated inhibition of virion-directed transcription. Virology (1972) 1.15
Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1979) 1.15